abrdn Life Sciences Investors
HQL
79 hedge funds and large institutions have $126M invested in abrdn Life Sciences Investors in 2024 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 30 increasing their positions, 23 reducing their positions, and 13 closing their positions.
30% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 23
11% more capital invested
Capital invested by funds: $113M → $126M (+$13M)
3.25% more ownership
Funds ownership: 32% → 35.25% (+3.3%)
0% more funds holding
Funds holding: 79 → 79 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Saba Capital Management
New York
|
+$14.4M |
| 2 |
AIA
Absolute Investment Advisers
Rosemary Beach,
Florida
|
+$8.28M |
| 3 |
KIM
Karpus Investment Management
Pittsford,
New York
|
+$4.78M |
| 4 |
QL
Quarry LP
New York
|
+$2.13M |
| 5 |
CA
Cetera Advisors
Denver,
Colorado
|
+$1.96M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CA
Cornerstone Advisors
Asheville,
North Carolina
|
-$6.4M |
| 2 |
Morgan Stanley
New York
|
-$5.21M |
| 3 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$3.54M |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$2.66M |
| 5 |
LSC
Logan Stone Capital
Chicago,
Illinois
|
-$1.88M |
HQL Hedge Fund Activity: Q1 2024 in Review
79 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q1 2024, worth a combined $126M — up 11% from $113M a quarter earlier.
Fund positioning in HQL was balanced in Q1 2024: 13 funds opened new positions, 13 closed out, 30 added to existing stakes and 23 trimmed.
The largest buyer was Saba Capital Management, adding an estimated $14.4M. The largest seller was Cornerstone Advisors, cutting an estimated $6.4M.
- 79 institutional investors held abrdn Life Sciences Investors (HQL) as of Q1 2024, unchanged from Q4 2023.
- Funds reported $126M of abrdn Life Sciences Investors stock for Q1 2024, up 11% quarter-over-quarter.
- 13 funds opened new abrdn Life Sciences Investors positions in Q1 2024 and 13 closed out, a net change of 0 holders.
- The largest abrdn Life Sciences Investors buyer in Q1 2024 was Saba Capital Management, an estimated $14.4M added.
- The largest abrdn Life Sciences Investors seller in Q1 2024 was Cornerstone Advisors, an estimated $6.4M sold.
Based on aggregated 13F filings for Q1 2024.